“Comparative Efficacy and Safety of Individual SGLT2 Inhibitors (Dapagliflozin, Empagliflozin, and Canagliflozin) on Kidney Function Decline in CKD: A Systematic Review and Network Meta-Analysis”. Open Access Indonesian Journal of Medical Reviews 5, no. 6 (November 12, 2025): 1772–1789. Accessed August 20, 2026. https://hmpublisher.com/index.php/OAIJMR/article/view/818.